Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia
· Delayed Price · Currency is AUD 0.295
0.00 (0.00%)
At close: Mar 6, 2026
ASX:LDX Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2018 |
| Revenue | 12.21 | 12.4 | 11.13 | 10.54 | 11.63 | 18.85 | Upgrade
|
| Revenue Growth (YoY) | -16.75% | 11.40% | 5.66% | -9.41% | -38.31% | 225.25% | Upgrade
|
| Cost of Revenue | 4.62 | 4.72 | 4.57 | 5.21 | 9.76 | 10.25 | Upgrade
|
| Gross Profit | 7.59 | 7.68 | 6.56 | 5.32 | 1.88 | 8.6 | Upgrade
|
| Selling, General & Admin | 15.98 | 13.11 | 11.5 | 11.64 | 21.89 | 18.36 | Upgrade
|
| Research & Development | 0.27 | 0.11 | 0.07 | 0.25 | 1.33 | 1.24 | Upgrade
|
| Operating Expenses | 18.7 | 15.75 | 14.22 | 15.56 | 28.78 | 19.6 | Upgrade
|
| Operating Income | -11.11 | -8.07 | -7.66 | -10.23 | -26.9 | -11 | Upgrade
|
| Interest Expense | -1.1 | -0.56 | -1.02 | -2.39 | -0.57 | -4.22 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.06 | 0.05 | 0.02 | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.94 | 1.44 | -0 | 2.04 | -0.02 | 0.19 | Upgrade
|
| EBT Excluding Unusual Items | -9.21 | -7.13 | -8.64 | -10.56 | -27.5 | -15.03 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -1.68 | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -1.02 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.2 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.05 | -0.05 | 0.04 | 1.59 | 0.02 | - | Upgrade
|
| Asset Writedown | - | - | - | - | -15.35 | - | Upgrade
|
| Pretax Income | -9.26 | -7.18 | -8.59 | -8.97 | -45.72 | -15.03 | Upgrade
|
| Net Income | -9.26 | -7.18 | -8.59 | -8.97 | -45.72 | -15.03 | Upgrade
|
| Net Income to Common | -9.26 | -7.18 | -8.59 | -8.97 | -45.72 | -15.03 | Upgrade
|
| Shares Outstanding (Basic) | 760 | 680 | 463 | 235 | 152 | - | Upgrade
|
| Shares Outstanding (Diluted) | 760 | 680 | 463 | 235 | 152 | - | Upgrade
|
| Shares Change (YoY) | 38.81% | 46.85% | 97.23% | 54.17% | - | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.04 | -0.30 | - | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.04 | -0.30 | - | Upgrade
|
| Free Cash Flow | -2.48 | -9.39 | 0.89 | -9.76 | -20.56 | -16.77 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | 0.00 | -0.04 | -0.14 | - | Upgrade
|
| Gross Margin | 62.17% | 61.93% | 58.96% | 50.54% | 16.12% | 45.62% | Upgrade
|
| Operating Margin | -90.97% | -65.07% | -68.79% | -97.13% | -231.32% | -58.35% | Upgrade
|
| Profit Margin | -75.81% | -57.93% | -77.19% | -85.15% | -393.16% | -79.72% | Upgrade
|
| Free Cash Flow Margin | -20.27% | -75.70% | 8.03% | -92.67% | -176.78% | -88.96% | Upgrade
|
| EBITDA | -10.58 | -7.46 | -6.97 | -9.07 | -25.67 | -10.69 | Upgrade
|
| EBITDA Margin | -86.60% | -60.19% | -62.64% | -86.10% | -220.70% | -56.70% | Upgrade
|
| D&A For EBITDA | 0.53 | 0.61 | 0.69 | 1.16 | 1.24 | 0.31 | Upgrade
|
| EBIT | -11.11 | -8.07 | -7.66 | -10.23 | -26.9 | -11 | Upgrade
|
| EBIT Margin | -90.97% | -65.07% | -68.79% | -97.13% | -231.32% | -58.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.